Feed

Earnings Highlights: Aflac, Cisco, Exxon, MasterCard, Shell, Time Warner ...

Here are some highlights from this past week's earnings coverage on BloggingStocks:

  • Aflac Inc. (AFL) posted better-than-expected Q4 earnings, though revenue fell short, and offered rosy guidance.
  • Avon Products Inc. (AVP) posted Q4 earnings growth that met analysts' expectations but shares sold off.
  • Cisco Systems inc. (CSCO) higher Q2 earnings topped the consensus estimate but cash flow fell.
  • CME Group Inc. (CME) fell short of analysts' Q4 profit expectations, resulting in price-target cuts.
  • ExxonMobil Corp. (XOM) posted better-than-expected Q4 earnings and revenue that boosted shares.

Continue reading Earnings Highlights: Aflac, Cisco, Exxon, MasterCard, Shell, Time Warner ...

Aetna Gets Ready to Announce Fourth Quarter Results

Aetna Fourth Quarter Earnings PreviewInsurance giant Aetna Inc. (AET) will be reporting its fourth quarter numbers tomorrow before the market opens.

Analysts are expecting to see the company show earnings of 42 cents per share. During the same period last year the company had earnings of 96 cents per share.

Continue reading Aetna Gets Ready to Announce Fourth Quarter Results

Serious Money: Cheapest Stocks Yet -- From 35 to 26

Is the market overpriced? Maybe it is cheap, or perhaps it is fairly valued. This is the third in a series examining the issue. Still, it has been my contention that it does not make any difference because no matter how the market is valued as a whole, there are plenty of cheap stocks out there to accommodate a large amount of capital allocation even this deep into a bull run.

If you would like to follow along from the beginning, the initial post screened stocks for lower than market average P/E ratios: Serious Money: Market Looks Cheap to Me -- 35 Stocks. In the second installment, I looked at yield and PEG ratios: Serious Money: Still Cheap Market -- 35 Stocks + Yields & Growth.

Continue reading Serious Money: Cheapest Stocks Yet -- From 35 to 26

Aflac Posts Better-Than-Expected Q4 Earnings

aflac fourth quarter earningsFollowing today's market close, insurance giant Aflac Incorporated (AFL) posted better-than-expected numbers for its fourth quarter.

Headed into this afternoon's earnings release, Wall Street was looking to see Aflac post earnings of $1.15 per share. The actual earnings came in better than expected at $1.18 per share.

Continue reading Aflac Posts Better-Than-Expected Q4 Earnings

Serious Money: Market Looks Cheap to Me -- 35 Stocks

We frequently receive comments that the market is overpriced. Recently one of our active readers commented that the market P/E was 30, which it's not. The actual rate (S&P forecast) has been even higher at times due to the volatile market.

The average should trend closer to the long term P/E of 15.7 in the next few years. However, I have reviewed companies often covered on our site and come up with a list of 35 stocks that have price-to-earning ratios below the long-term average already. I think there are dozens of bargains regardless of the status of the overall market.

Continue reading Serious Money: Market Looks Cheap to Me -- 35 Stocks

The 10/10 Dividend Club

Looking for dividend-paying blue chip stocks? Chuck Carlson is a leading expert on dividend reinvestment plans.

In The DRIP Investor, he looks at the 10/10 Club -- stocks that have boosted their payouts by 10% a year for at least 10 years. He explains,"The table below features seven stocks that belong to the exclusive '10/10' club:

Continue reading The 10/10 Dividend Club

Top Picks for 2010: Aflac (AFL)

This post is part of a special report, Top Picks for 2010, the 27th annual survey in which TheStockAdvisors.com asks the nation's leading advisors for their single favorite stock for the new year. See all 80 stocks listed here.

"Aflac (AFL) is best known in the U.S. for its 'duck ads,' but actually earns over 75% of its money from Japan," says Dirk Van Dijk.

In selecting the stock as his top pick for 2010, the strategist for Zacks.com, recalls "Aflac happens to be an old favorite of mine, a stock that I first recommended back in 1991." Here's his current update.

Continue reading Top Picks for 2010: Aflac (AFL)

Aflac's uptrend continues

Steady as she goes, with Aflac (AFL), to borrow a Star Trek phrase, and that's why I'm reiterating my buy rating for the company, first recommended on May 28, 2009 at a price of $36.07. If you bought AFL in May, you're up about 30%.

After a slow start, institutional investors in mid-2010 finally noticed that not every insurer would be wiped-out by collateralized debt obligations and bad bonds. Aflac boasts primarily high-quality corporate debt, Wall Street realized this in the spring, and it's been off to the races ever since. Aflac is one of the largest sellers of supplemental insurance in the U.S. and is a major cancer-insurance company in Japan (14 million policies).

Continue reading Aflac's uptrend continues

Dividend growth trio: Aflac, Medtronic and Colgate-Palmolive

"One way to build an inflation hedge into your investment cash flows is to focus on stocks that are likely to boost their dividends on a regular basis," explains dividend specialist Chuck Carlson.

In his The DRIP Investor, which focuses on blue chip companies offering dividend reinvestment programs, he notes, "Since dividends are paid with cold cash, they can't be faked. Either you pay the dividend or you don't. They can't be some figment of accounting magic." Here, he looks at three favorite blue chips with strong dividend records.

Continue reading Dividend growth trio: Aflac, Medtronic and Colgate-Palmolive

Earnings highlights: Aflac, Avon, BP, Hershey, Kellogg, Nintendo, P&G, Sprint ...

Here are some highlights from last week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: Aflac, Avon, BP, Hershey, Kellogg, Nintendo, P&G, Sprint ...

Aetna, Aflac, WellPoint rise following earnings releases

Even as the battle over health care reform rages on Capitol Hill, we are seeing a flurry of third quarter reports from insurers.

Aetna Inc. (NYSE: AET) reported Thursday that its third-quarter profit rose 18% from a year ago to $308.2 million, or $0.69 per share, topping Wall Street's expectations. Revenue came in at $8.72 billion, versus the consensus of $8.68 billion. Aetna also said share repurchases totaled 3.9 million at a cost of $114 million in the third quarter of 2009.

Continue reading Aetna, Aflac, WellPoint rise following earnings releases

Aflac is in an uptrend

It appears the market is finally starting to see the value in Aflac Incorporated (NYSE: AFL), hence it goes without saying that I'm reiterating my Buy rating for company, first recommended on May 28, 2009 at a price of $36.07.

Aflac is another one of those insurers that was rudely treated by Wall Street during the panicked frenzy that gripped markets with the onset of the financial crisis. And it was rude: the Street took AFL's shares from a high of $68 to about $11, basically on the fear that Aflac would incur major losses from European bank hybrid bonds, including the threat of bank nationalization.

Continue reading Aflac is in an uptrend

Dropping the 'public option' could insure some stocks' health

Regardless of how you feel about a public health insurance option offered by the government, interest at the policy level seems to be waning recently. If Democrats drop the idea of a public option as a component of health care reform, health insurance companies could benefit.

The way I see it, if the government starts offering health insurance as a public provider then new supply will have entered the market. According to my college Econ 101 text book, that new supply would have shifted the supply and demand curves towards lower prices and maybe lower profits.

Continue reading Dropping the 'public option' could insure some stocks' health

Closing Bell: Bears win decisive victory, sort of (AET, AFL, AEZS, FSLR, LOW)

Today's weakness was due to two issues. First was a much needed pullback after a monster run-up in the markets. Second was a weak Asian market turnout that spilled over to the west on concerns that maybe the recent gains did not add up to as high as share prices had gone. The stronger NY Fed District manufacturing data was merely a footnote. The bears might claim a decisive victory because there were no major rallies, but keep in mind that this is a summer Monday with light trading desks.

Here were today's unofficial closing bell levels:

Dow 9,135.34 -186.06 (-2.00%)
S&P 500 979.72 -24.37 (-2.43%)
Nasdaq 1,930.84 -54.68 (-2.75%)

Top 10 Analyst Calls

Continue reading Closing Bell: Bears win decisive victory, sort of (AET, AFL, AEZS, FSLR, LOW)

Next Page »

Symbol Lookup
IndexesChangePrice
DJIA-103.849,908.39
NASDAQ-15.072,126.05
S&P 500-9.451,056.74

Last updated: February 09, 2010: 07:25 AM

Hot Stocks

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

CNNMoney Headlines

More CNNMoney.com

Financial Times Headlines

More Financial Times

CNBC Headlines

More CNBC.com

SmartMoney Headlines

More SmartMoney

Fox Business Headlines

More Fox Business

Engadget Headlines

More Engadget

DailyFinance Headlines

More DailyFinance

WalletPop Headlines

More WalletPop

Aol Small Business Headlines

More Aol Small Business

Luxist Headlines

More Luxist

HousingWatch Headlines

More HousingWatch

Aol News Headlines

More Aol News